Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO<sub>2</sub>.

Publication Year: 2024

DOI:
10.1186/s12931-023-02602-3

PMCID:
PMC10851544

PMID:
38331869

Journal Information

Full Title: Respir Res

Abbreviation: Respir Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials raw data will be available upon request at www zenodo org . availability of data and materials raw data will be available upon request at www zenodo"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was approved by the Ethics Committee of Centro Cardiologico Monzino and registered as R1174/20 CCM 1237. Each subject provided written consent to the study. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research was supported by Italian Ministry of Health (ricerca corrente)."

Evidence found in paper:

"The study was approved by the Ethics Committee of Centro Cardiologico Monzino and registered as R1174/20 CCM 1237. Declarations: Ethics approval and consent to participateThe study was approved by the Ethics Committee of Centro Cardiologico Monzino and registered as R1174/20 CCM 1237. Each subject provided written consent to the study.: Consent for publicationNot applicable.: Competing interestsThe authors declare that they have no competing interests. Ethics approval and consent to participate: The study was approved by the Ethics Committee of Centro Cardiologico Monzino and registered as R1174/20 CCM 1237. Each subject provided written consent to the study."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025